Navigation Links
inVentiv Health Selected to Provide Sales Operations Support for Santarus
Date:11/14/2011

BURLINGTON, Mass., Nov. 14, 2011 /PRNewswire/ -- inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced today that it has been selected by the specialty biopharmaceutical company Santarus, Inc. to provide sales operations support, as well as recruiting and sales force automation services, for the organization's prescription products for Type 2 diabetes.

inVentiv Health will deliver the outsourced sales services through the company's Selling Solutions business. It offers flexible staffing solutions to a wide range of clients in the pharmaceutical, biotechnology, medical device, diagnostic, long-term care, and pharmacy and managed care industries.

"inVentiv is extremely pleased to be collaborating with Santarus again," said Paul Mignon, President, inVentiv Health Selling Solutions. "We look forward to putting our experienced sales teams and best-in-class recruiting and sales force automation services to work for our long-term client and its vitally important medicines for patients."

Gerry Proehl, President and CEO, Santarus, Inc., said: "We have contracted with inVentiv Health to expand our field sales organization based on our positive past experience with this organization. By working with inVentiv and adding sales representatives, we intend to increase call frequency and share of voice with our called-on physicians, as well as improve sales representative efficiency by reducing territory size and increasing the number of sales calls made each day."  

About Santarus

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on GLUMETZA® (metformin hydrochloride extended release tablets) and CYCLOSET® (bromocriptine mesylate) tablets, w
'/>"/>

SOURCE inVentiv Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. AWAC Becomes inVentiv Medical Management™
2. Ocean Tomo Study Ranks Top 25 Most Inventive Companies for Bloomberg BusinessWeek
3. Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
4. iSource Networks Partners with inVentiv Health to Develop New Technology Platform for Reaching Healthcare Consumers
5. inVentiv Health to Announce First Quarter 2009 Results and Conduct Conference Call on Friday, May 8
6. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
7. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
8. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
9. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
10. Sangamo BioSciences Announces Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference
11. "Tomorrows Health" TV Series Showing the Life Science Industrys Quest to Save and Improve Lives, to Air on Select NBC Stations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Dr. Greg Leyer of UAS ... Scripps Natural Supplements Pre-Conference seminar on probiotics in San Diego, ... annual continuing education conference for health care professionals. This year’s ... topic of probiotics in health. Dr. Leyer spoke about the ...
(Date:1/22/2015)...   Cypher Genomics, Inc., the leading genome ... SQNM ), the leading molecular diagnostics company, today ... prenatal tests (NIPT). Through this agreement, Sequenom will ... advance analysis of clinically-relevant fetal sub-chromosomal variants detected ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
(Date:12/24/2014)... St. Louis, Missouri (PRWEB) December 23, 2014 ... Swiss biotechnology company, Syngenta, are in the process of being ... consolidated case is In Re: Syngenta AG MIR 162 Corn ... the District of Kansas. , Management of the Syngenta GMO ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2
... New Releases for the Company Building on Milestones ... April 20 DXL625 monoclonal antibodies ... their ability to attach and deplete NHL in ... at InNexus Biotechnology Inc. (Toronto Stock Exchange: IXS.V, ...
... Xennex Inc. (Xennex) announced today that it ... provided Satoris with access to GeneCards(R) and associated ... input from the advanced prototype of GeneCards(R) version ... Satoris is utilizing GeneCards and the related technology ...
... groups including the mentally ill, the disabled and ... fare worse than others in the aftermath of natural ... , Now, a new study by UCLA researchers ... terrorism-related fears and make more behavioral changes based on ...
Cached Biology Technology:AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies 2AACR 100th Annual Meeting Highlights Superior Ability of InNexus' DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies 3Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions 2Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions 3Disabled and other vulnerable groups more susceptible to terrorism fears 2
(Date:12/24/2014)... its launch in December 2014, the 1U™ app ... trying to remember their usernames and passwords through replacing the ... To assist people who have struggled to remember usernames and ... and focuses on redefining identity, announced today that it is ...
(Date:12/22/2014)... 2014  The 2014 Holiday Season may be the brightest ... reports that the long anticipated floodgates for consumer biometrics ... for smart phones, tablets, and wearable mobile devices that ... billion users with nearly 4.8 billion biometric devices by ...
(Date:12/19/2014)... Inc., the leading personal genetics company, today announced the publication ... of individuals from across the United States ... hundred years ago, the United States ... continents. This study illuminates how American history and the ongoing ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... therapeutic dose of radiation lost up to 39% of ... inner bone's weight bearing connections by up to 64%, ... edition of the Journal of Applied Physiology, has implications ... long space flights. , "We were really surprised at ...
... of a new technique for detecting brain damage caused by ... scientists at The University of Manchester. Professor Gareth Morris of ... University of Birmingham are to lead the development of a ... , A stroke is caused when part of the blood ...
... is a mystery. Butterfly or baby, cells organize themselves ... and over, patterns emerge in all living creatures. Spiders ... encased in an elegant spiral shell. , This phenomenon ... the forces that govern it are far from clear. ...
Cached Biology News:One therapeutic dose of radiation causes 30 percent spongy bone loss in mice 2One therapeutic dose of radiation causes 30 percent spongy bone loss in mice 3The shape of life: research sheds light on how cells take shape 2
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... SilverSNAP Stain for Mass Spectrometry Applications ... spectrometry (MS) has emerged as a powerful ... of 2-D gels is now an important ... that leads ultimately to identification of specific ...
... Extraction Reagent is a liquid, ... means no scraping, no freeze-thaw ... M-PER Reagent, rapid lysis occurs ... room temperature, yielding 25% more ...
... Kits with ammonium sulfate are compatible with ... as Tfl, Tth, and Pfu DNA polymerases. ... PCR systems in one experiment by adding ... into the PreMixes supplied with the kit. ...
Biology Products: